Page 24
www.opioidprescribing.com/dental. b. Advancing Pain Management in Oregon. Online training from the Pain Management Commission of the Oregon Health Authority: www.oregon.gov/oha/OHPR/PMC/Pages/index.aspx. c. American Dental Association statement on use of opioids in the treatment of dental pain. See Appendix B. d. Specialists should follow additional guidelines from their specialty associations (e.g., American Academy of Pediatric Dentistry, American Academy of Pediatrics, American Association of Oral and Maxillofacial Surgeons, American Association of Endodontists). 5. Consult with the treating addiction specialist if the patient is in active treatment for substance use disorder and coordinate before prescribing opioids. Evidence‐based care for opioid use disorder includes medication‐assisted treatment (e.g., methadone, buprenorphine‐naloxone). 6. Contact the Substance Abuse and Mental Health Services Administration (SAMHSA)’s Providers’ Clinical Support System for Opioids (PCSS‐O) and Medication Assisted Treatment (PCSS‐MAT) for treatment issues. Expert mentors are available to assist with questions or concerns about opioids and treatment of substance use disorders. 7. Support patients who are in successful long‐term recovery from a previoussubstance use disorder of any kind (e.g., alcohol, opioids, heroin, methamphetamine) and have committed to a drug‐free lifestyle. a. Avoid “just in case” opioid prescriptions. b. If severe post‐operative pain is expected, take special precautions in providing opioids. For example, involve a family member, 12‐step program sponsor, or addiction counselor in medication administration, and advise increasing attendance at meetings and/or counseling sessions during the post‐operative period. Dental Guideline on Prescribing Opioids for Acute Pain Management Adopted by the Bree Collaborative, September 27th, 2017 Page 10 of 12 Acknowledgements The Bree Collaborative and Washington State Agency Medical Directors’ Group wish to acknowledge the many individuals and groups from both the private and public sectors who provided crucial consultation and input to this guideline. Their clinical, scientific, and technical expertise helped ensure that this guideline would be relevant, accurate, and of practical use to dental prescribers. Every effort was made to create a guideline as evidence-based as possible. Where scientific evidence was insufficient or unavailable, the best clinical opinions and consensus of the advisory group were used. We are grateful for the time and efforts made by each of the following persons: Silver Spring, Md. — The Food and Drug Administration announced Aug. 22 that it will develop prescribing guidelines in an effort to give health care providers "the most current and comprehensive guidance on the appropriate management of pain."To do this, the FDA said it has awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for "appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures.""The primary scope of this work is to understand what evidence is needed to ensure